Additional file 1: of Cost analysis of rapid diagnostics for drug-resistant tuberculosis

Erik Groessl, Theodore Ganiats, Naomi Hillery, Andre Trollip, Roberta Jackson, Donald Catanzaro, Timothy Rodwell, Richard Garfein, Camilla Rodrigues, Valeriu Crudu, Thomas Victor & Antonino Catanzaro
Table S1 Clinical and Laboratory Characteristics of the Patients. Table S2 Agreement between three rapid tests and MGIT for detection of resistance for isoniazid (INH), rifampin (RIF), amikacin (AMK), capreomycin (CAP), kanamycin (KAN), moxifloxacin (MOX), and ofloxacin (OFX). Table S3 Proportion of total assay runs that produced interpretable results from three diagnostic platforms (LPA, PSQ and MODS) with the ability to detect resistance to isoniazid (INH), rifampin (RIF), amikacin (AMK), capreomycin (CAP), kanamycin (KAN), moxifloxacin...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.